Nan Shan Life Insurance Co. Ltd. Acquires 1,408 Shares of Synopsys, Inc. $SNPS

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

Nan Shan Life Insurance Co. Ltd. lifted its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 1.6% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 90,563 shares of the semiconductor company's stock after purchasing an additional 1,408 shares during the period. Nan Shan Life Insurance Co. Ltd. owned 0.06% of Synopsys worth $38,838,000 at the end of the most recent reporting period.

A number of other hedge funds have also added to or reduced their stakes in SNPS. Legacy Financial Advisors Inc. grew its position in shares of Synopsys by 8.1% during the 1st quarter. Legacy Financial Advisors Inc. now owns 993 shares of the semiconductor company's stock worth $426,000 after buying an additional 74 shares during the period. Wellington Management Group LLP boosted its stake in Synopsys by 5.2% during the first quarter. Wellington Management Group LLP now owns 1,112,628 shares of the semiconductor company's stock worth $477,151,000 after acquiring an additional 54,868 shares in the last quarter. Aviso Financial Inc. bought a new position in Synopsys during the first quarter worth $616,000. Brooklyn Investment Group boosted its stake in Synopsys by 26.5% during the first quarter. Brooklyn Investment Group now owns 764 shares of the semiconductor company's stock worth $328,000 after acquiring an additional 160 shares in the last quarter. Finally, Corient IA LLC bought a new position in Synopsys during the first quarter worth $377,000. 85.47% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on SNPS. The Goldman Sachs Group began coverage on shares of Synopsys in a research note on Thursday, July 10th. They set a "buy" rating and a $620.00 target price on the stock. Needham & Company LLC reissued a "buy" rating and set a $660.00 target price (up from $650.00) on shares of Synopsys in a research note on Tuesday, July 15th. Bank of America boosted their price objective on Synopsys from $575.00 to $625.00 and gave the company a "buy" rating in a report on Wednesday, July 16th. Rosenblatt Securities boosted their price objective on Synopsys from $625.00 to $650.00 and gave the company a "buy" rating in a report on Friday, July 25th. Finally, Stifel Nicolaus set a $550.00 price objective on Synopsys in a report on Monday, April 28th. Twelve analysts have rated the stock with a Buy rating and one has given a Hold rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $626.79.

Synopsys Stock Performance

SNPS stock traded up $8.35 during midday trading on Friday, hitting $606.52. The company's stock had a trading volume of 863,153 shares, compared to its average volume of 1,421,519. The stock's 50-day moving average price is $567.73 and its 200 day moving average price is $500.38. The company has a quick ratio of 6.85, a current ratio of 7.02 and a debt-to-equity ratio of 1.01. Synopsys, Inc. has a 1 year low of $365.74 and a 1 year high of $651.73. The stock has a market cap of $94.11 billion, a price-to-earnings ratio of 43.79, a PEG ratio of 3.95 and a beta of 1.15.

Synopsys (NASDAQ:SNPS - Get Free Report) last posted its quarterly earnings data on Wednesday, May 28th. The semiconductor company reported $3.67 earnings per share for the quarter, topping the consensus estimate of $3.40 by $0.27. The business had revenue of $1.60 billion for the quarter, compared to analysts' expectations of $1.60 billion. Synopsys had a return on equity of 17.09% and a net margin of 34.77%.The business's revenue was up 10.3% on a year-over-year basis. During the same quarter in the previous year, the firm earned $3.00 earnings per share. Synopsys has set its FY 2025 guidance at 15.110-15.190 EPS. Q3 2025 guidance at 3.820-3.87 EPS. On average, equities analysts forecast that Synopsys, Inc. will post 10.64 EPS for the current year.

Insider Buying and Selling at Synopsys

In other Synopsys news, CEO Sassine Ghazi sold 11,366 shares of the business's stock in a transaction on Monday, June 2nd. The stock was sold at an average price of $457.93, for a total value of $5,204,832.38. Following the sale, the chief executive officer directly owned 71,589 shares in the company, valued at $32,782,750.77. The trade was a 13.70% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Shelagh Glaser sold 7,310 shares of the business's stock in a transaction on Friday, June 6th. The shares were sold at an average price of $485.72, for a total value of $3,550,613.20. Following the completion of the sale, the chief financial officer owned 15,291 shares in the company, valued at approximately $7,427,144.52. The trade was a 32.34% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 27,686 shares of company stock worth $13,001,048 over the last ninety days. 0.62% of the stock is currently owned by company insiders.

Synopsys Profile

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.